Prosus receives EU approval for Just Eat Takeaway.com acquisition

Fabricio Bloisi Group Chief Executive Officer and Executive Director Prosus N.V.
Fabricio Bloisi Group Chief Executive Officer and Executive Director - Prosus N.V.
0Comments

Prosus has received approval from the European Commission to proceed with its acquisition of Just Eat Takeaway.com (JET), completing the final regulatory step required for the deal. The company announced that all necessary clearances were obtained ahead of schedule.

With this clearance, Prosus plans to advance its strategy to develop a leading technology ecosystem in Europe, focusing on food delivery, consumer platforms, and artificial intelligence. Prosus intends to use its investment in AI to improve customer experience and expand these solutions across JET’s operations.

Fabricio Bloisi, CEO of Prosus, stated: “We’re thrilled by the European Commission’s swift approval of our acquisition of JET. Innovation doesn’t wait, and we can now get to work quickly, as AI is rapidly reshaping food delivery. This milestone marks a bold investment in Europe’s AI future and strengthens our commitment to the continent.

“With JET’s trusted brand and leading positions, combined with Prosus’s technical expertise and global scale, we’re poised to accelerate growth, enhance customer experiences, and unlock new value for our partners, drivers, and shareholders. Our ambition is clear: to build a true European tech champion and lead the next chapter in food delivery innovation.”

As part of its engagement with regulators over recent months, Prosus has agreed to reduce its equity stake in Delivery Hero to below 10 percent within one year of receiving European Commission approval. The company also committed not to recommend or appoint any individual associated with Naspers or Prosus to Delivery Hero’s management or supervisory boards.

These measures are intended to support competition in Europe’s food delivery sector and enable a smooth integration of JET into the Prosus group.

The offer period for shareholders will end on October 1, 2025 at 17:40 CEST. If all conditions are met by that date—including reaching the required acceptance threshold—Prosus will declare the offer unconditional within three business days after closing.

For more information about how shareholders can tender their shares, details are available on the Prosus website.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.